Lupton Biomedical expects three years of exception growth due to the demand for its low volume syringes, pcr tests and vaccines as a result of the pandemic. Their dividend of $1.1 (Do) will increase by 8% for three years before returning the regular growth rate of 4%. Find the value of the shares today if Ke is 12.8%.